Ubs Asset Management Americas Inc Geron Corp Transaction History

Ubs Asset Management Americas Inc

$379 Billion
Q1 2025

A detailed history of Ubs Asset Management Americas Inc transactions in Geron Corp stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 1,372,016 shares of GERN stock, worth $1.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,372,016

Previous 1,267,176 8.27%

Holding current value

$1.99 Million

Previous $4.49 Million 51.37%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 19, 2025	BUY	$1.59 - $3.6 $166,695 - $377,424	104,840 Added 8.27%	1,372,016 $2.18 Million
Q4 2024 Feb 14, 2025	BUY	$3.3 - $4.44 $813,228 - $1.09 Million	246,433 Added 24.14%	1,267,176 $4.49 Million
Q3 2024 Nov 14, 2024	BUY	$4.17 - $4.99 $494,928 - $592,253	118,688 Added 13.16%	1,020,743 $4.63 Million
Q2 2024 Aug 13, 2024	BUY	$3.1 - $5.09 $1.58 Million - $2.59 Million	508,209 Added 129.04%	902,055 $3.82 Million
Q3 2023 Nov 13, 2023	BUY	$2.11 - $3.28 $133,377 - $207,335	63,212 Added 19.12%	393,846 $834,000
Q1 2023 May 15, 2023	BUY	$2.14 - $3.4 $86,154 - $136,880	40,259 Added 13.86%	330,634 $717,000
Q3 2022 Nov 14, 2022	BUY	$1.67 - $2.94 $22,638 - $39,854	13,556 Added 4.9%	290,375 $679,000
Q2 2021 Aug 16, 2021	SELL	$1.25 - $1.83 $89,946 - $131,681	-71,957 Reduced 20.63%	276,819 $390,000
Q1 2021 May 14, 2021	BUY	$1.52 - $2.1 $67,864 - $93,760	44,648 Added 14.68%	348,776 $551,000
Q3 2020 Nov 13, 2020	BUY	$1.59 - $2.19 $104,588 - $144,056	65,779 Added 27.6%	304,128 $529,000
Q2 2020 Aug 14, 2020	BUY	$1.05 - $2.18 $168,925 - $350,720	160,881 Added 207.67%	238,349 $519,000
Q1 2020 May 15, 2020	SELL	$0.89 - $1.49 $12,572 - $21,047	-14,126 Reduced 15.42%	77,468 $92,000
Q4 2019 Feb 14, 2020	SELL	$1.27 - $1.54 $22,120 - $26,823	-17,418 Reduced 15.98%	91,594 $124,000
Q3 2019 Nov 14, 2019	BUY	$1.15 - $1.59 $11,318 - $15,648	9,842 Added 9.92%	109,012 $144,000
Q1 2019 May 14, 2019	BUY	$1.01 - $1.83 $2,345 - $4,249	2,322 Added 2.4%	99,170 $0
Q2 2018 Aug 14, 2018	BUY	$3.29 - $4.82 $3,948 - $5,784	1,200 Added 1.25%	96,848 $0
Q1 2018 May 14, 2018	BUY	$1.81 - $5.98 $34,884 - $115,252	19,273 Added 25.23%	95,648 $0
Q3 2017 Nov 13, 2017	BUY	$1.99 - $2.65 $151,986 - $202,393	76,375	76,375 $0

Others Institutions Holding GERN

# of Institutions

295

Shares Held

496M

Call Options Held

799K

Put Options Held

463K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $548M
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Geron Corp Transaction History